|Bid||5.42 x 1800|
|Ask||5.48 x 800|
|Day's Range||5.31 - 5.60|
|52 Week Range||4.68 - 8.47|
|Beta (3Y Monthly)||1.07|
|PE Ratio (TTM)||1.04|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
SIGA Technologies, Inc. (SIGA) (SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, June 18, 2019. Participants may also call (877) 407-6184 (United States/Canada) or (201) 389-0877 (International) and request the SIGA Technologies call or provide confirmation code 13691653. SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market.
“Meridian, a leader within the global medical countermeasure industry, has sold products in over 30 countries worldwide and has been marketing and distributing emergency care treatment options to military and civilian authorities for more than 50 years.
Oaktree Capital Management is an alternative investment manager that was launched back in 1995 by a group of individuals who had been working together at TCW Group. Among them was Howard Marks, who is the fund’s current co-Chairman. Mr. Marks, a chartered financial analyst, earned a B.S.Ec. degree cum laude from the Wharton School of […]
Raw Materials expected to be used to Support Manufacture of 363,070 Courses of Oral TPOXX NEW YORK, May 20, 2019 -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a.
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and investors' positions as of the end of the fourth quarter. You can find write-ups about an individual hedge fund's trades on numerous financial news websites. […]
With a market cap of $ 728.29 million, Rite Aid Corp. (RAD) is trading with a price-earnings ratio of 0.39 and a price-book ratio of 0.49. The share price has fallen 55% over the last 12 months and is trading 68.19% below its 52-week high and 12.4% above its 52-week low. Warning! GuruFocus has detected 5 Warning Signs with RAD.
SIGA Technologies, Inc. (SIGA) (SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez, SIGA’s Chief Executive Officer, will present at the 8th Annual SVB Leerink Global Healthcare Conference at 9:00 am ET on Friday, March 1, 2019 in New York. SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market.
NEW YORK, Nov. 15, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Is Immersion Corporation (NASDAQ:IMMR) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research. We do so because hedge funds and other elite investors have numerous Ivy league graduates, expert network advisers, and supply chain tipsters working or consulting for them. There is not a shortage of […]
SIGA Technologies, Inc. (SIGA) (SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has entered into an agreement to sell its medical countermeasures priority review voucher (PRV) for a lump sum payment of $80 million. SIGA was awarded the PRV in July 2018 upon approval by the U.S. Food and Drug Administration (FDA) of oral TPOXX® for the treatment of smallpox. The PRV was awarded by FDA under a provision that encourages development of medical countermeasures enacted as part of the 21st Century Cures Act (Public Law 114-255).
Siga Technologies (NASDAQ: SIGA) announced the FDA's approval of TPOXX, or tecovirimat. The drug consists of an antiviral treatment designed to diminish the effects of smallpox upon outbreak and is the first approved treatment of its kind. The smallpox drug's importance is twofold.